Glaser Dee Anna, Hebert Adelaide A, Pariser David M, Solish Nowell
Department of Dermatology, Saint Louis University, Missouri, USA.
Cutis. 2007 May;79(5 Suppl):18-28.
When topical therapy and tap water iontophoresis (TWI) fail, are unavailable, or are deemed unsatisfactory by patients with palmar or plantar hyperhidrosis (HH), the next logical treatment option is botulinum toxin type A (BTX-A). Skill and precision are required to treat palmar and plantar HH because of the dense innervation in the palms and soles. This article describes best practice techniques for BTX-A (Botox), including suggested dilution and syringe selection, injection technique, dose and injection grids, and anesthesia recommendations. In addition, general BTX-A background and special considerations for treating palmar and plantar HH are provided. Insurance reimbursement for treating HH with BTX-A can be challenging; navigating the insurance reimbursement process will be discussed.
当局部治疗和自来水离子电渗疗法（TWI）无效、无法使用或被手掌或足底多汗症（HH）患者认为不满意时，下一个合理的治疗选择是A型肉毒杆菌毒素（BTX-A）。由于手掌和脚底的神经分布密集，治疗手掌和足底多汗症需要技巧和精准度。本文介绍了BTX-A（保妥适）的最佳实践技术，包括建议的稀释度和注射器选择、注射技术、剂量和注射网格以及麻醉建议。此外，还提供了BTX-A的一般背景信息以及治疗手掌和足底多汗症的特殊注意事项。使用BTX-A治疗多汗症的保险报销可能具有挑战性；将讨论如何应对保险报销流程。
